Author

Drew Provan

Reader in Haematology, Barts & The London School of Medicine - Cited by 14,145 - autoimmune hematology - ITP

Biography

Dr. Drew is an experienced haematologist, with special interest in immune thrombocytopenia. Currently he is working at Barts and The London School of Medicine and Dentistry, London, UK. He has many publications. His area of expertise is Hematologic Diseases, Platelets, Anemia, Erythropoiesis, Guidelines. He is keen to exploit digital technology in medicine and molecular biology, would be keen to work with an innovative leader (Microsoft, Apple, BT) to help shape digital medicine
Title
Cited by
Year
Updated international consensus report on the investigation and management of primary immune thrombocytopenia
D Provan, DM Arnold, JB Bussel, BH Chong, N Cooper, T Gernsheimer, ...Blood advances 3 (22), 3780-3817, 2019201
630
2019
Practical guidance for the management of adults with immune thrombocytopenia during the COVID‐19 pandemic
S Pavord, J Thachil, BJ Hunt, M Murphy, G Lowe, M Laffan, M Makris, ...British Journal of Haematology 189 (6), 1038-1043, 2020202
121
2020
Oxford handbook of clinical and laboratory investigation
D ProvanOxford university press, 2018201
74
2018
ABC of clinical haematology
D Provan, C HarrisonJohn Wiley & Sons, 2023202
70
2023
Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia
DB Cines, J Wasser, F Rodeghiero, BH Chong, M Steurer, D Provan, ...Haematologica 102 (8), 1342, 2017201
56
2017
Immune thrombocytopenia (ITP) World Impact Survey (I‐WISh): impact of ITP on health‐related quality of life
N Cooper, A Kruse, C Kruse, S Watson, M Morgan, D Provan, W Ghanima, ...American journal of hematology 96 (2), 199-207, 2021202
50
2021
Immune thrombocytopenia (ITP) World Impact Survey (iWISh): patient and physician perceptions of diagnosis, signs and symptoms, and treatment
N Cooper, A Kruse, C Kruse, S Watson, M Morgan, D Provan, W Ghanima, ...American journal of hematology 96 (2), 188-198, 2021202
48
2021
Recent advances in the mechanisms and treatment of immune thrombocytopenia
D Provan, JW SempleEBioMedicine 76, 2022202
23
2022
The role of splenectomy in autoimmune hematological disorders: Outdated or still worth considering?
J Sys, D Provan, A Schauwvlieghe, S Vanderschueren, D DierickxBlood Reviews 31 (3), 159-172, 2017201
19
2017
Tapering and discontinuation of thrombopoietin receptor agonist therapy in patients with immune thrombocytopenia: results from a modified Delphi panel
N Cooper, QA Hill, J Grainger, JP Westwood, C Bradbury, D Provan, ...Acta Haematologica 144 (4), 418-426, 2021202
17
2021
Manual de hematología clínica
D Provan, T Baglin, I Dokal, J De VosElsevier Health Sciences, 202
17
2017
The prevention of glucocorticoid-induced osteoporosis in patients with immune thrombocytopenia receiving steroids: A British Society for Haematology Good Practice Paper
QA Hill, JD Grainger, J Thachil, D Provan, G Evans, M Garg, C Bradbury, ...Br J Haematol 185 (3), 410-7, 2019201
15
2019
Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry
IU Doobaree, A Newland, V McDonald, R Nandigam, L Mensah, S Leroy, ...European Journal of Haematology 102 (5), 416-423, 2019201
13
2019
A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonists
J Thachil, C Bagot, C Bradbury, N Cooper, W Lester, JD Grainger, G Lowe, ...British journal of haematology 10 (4), 591-594, 20120
8
2018
Iron deficiency anaemia
D ProvanABC of clinical haematology, 1, 2018201
7
2018
Qualitative study to support the content validity of the immune thrombocytopenia (ITP) Life Quality Index (ILQI)
N Cooper, A Cuker, N Bonner, W Ghanima, D Provan, M Morgan, B Taylor, ...British Journal of Haematology 194 (4), 759-7, 2021202
6
2021
Incidence of adult primary immune thrombocytopenia in England—An update
IU Doobaree, K Conway, H Miah, A Miah, M Makris, Q Hill, N Cooper, ...European Journal of Haematology 109 (3), 238-249, 2022202
6
2022
Qualitative research to support the content validity of the Immune Thrombocytopenia (ITP) Life Quality Index (ILQI)
L Grant, N Bonner, A Harper, B Taylor, N Ramscar, S Watson, W Ghanima, ...BRITISH JOURNAL OF HAEMATOLOGY 181, 19-19, 2018201
6
2018
proposal for a new protocol for the management of immune thrombocytopenia (ITP)
TJ González-López, D ProvanAdvances in Therapy 39 (6), 2287-2291, 2022202
5
2022
Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia
R Viana, D D’Alessio, L Grant, N Cooper, D Arnold, M Morgan, D Provan, ...Advances in Therapy 38, 5791-5808, 2021202
4
2021

Referred From: https://scholar.google.com/citations?user=3HsYx-sAAAAJ&hl=en

Cited by
Citations 14145
h-index 47
i10-index 71
Recommended Journals
Open Access Journals